CYTK
Price
$65.34
Change
+$0.54 (+0.83%)
Updated
Apr 26, 6:59 PM EST
10 days until earnings call
KRON
Price
$1.00
Change
+$0.02 (+2.04%)
Updated
Apr 26, 6:59 PM EST
10 days until earnings call
Ad is loading...

Compare predictions CYTK vs KRON

Header iconCYTK vs KRON Comparison
Open Charts CYTK vs KRONBanner chart's image
Cytokinetics
Price$65.34
Change+$0.54 (+0.83%)
Volume$318.21K
CapitalizationN/A
Kronos Bio
Price$1.00
Change+$0.02 (+2.04%)
Volume$233.23K
CapitalizationN/A
View a ticker or compare two or three
CYTK vs KRON Comparison Chart

Loading...

CYTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KRONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CYTK vs. KRON commentary
Apr 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongSell and KRON is a Hold.

COMPARISON
Comparison
Apr 28, 2024
Stock price -- (CYTK: $65.34 vs. KRON: $1.00)
Brand notoriety: CYTK and KRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 36% vs. KRON: 98%
Market capitalization -- CYTK: $6.83B vs. KRON: $60.1M
CYTK [@Biotechnology] is valued at $6.83B. KRON’s [@Biotechnology] market capitalization is $60.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $568.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 2 FA rating(s) are green whileKRON’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 2 green, 3 red.
  • KRON’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than KRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 2 TA indicator(s) are bullish while KRON’s TA Score has 3 bullish TA indicator(s).

  • CYTK’s TA Score: 2 bullish, 6 bearish.
  • KRON’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, KRON is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -3.27% price change this week, while KRON (@Biotechnology) price change was -0.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

CYTK is expected to report earnings on Aug 01, 2024.

KRON is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CYTK with price predictions.
OPEN
A.I.dvisor published
a Summary for KRON with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CYTK($6.83B) has a higher market cap than KRON($60.1M). KRON YTD gains are higher at: -20.000 vs. CYTK (-21.739).
CYTKKRONCYTK / KRON
Capitalization6.83B60.1M11,369%
EBITDAN/AN/A-
Gain YTD-21.739-20.000109%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
22
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKKRON
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
View a ticker or compare two or three
Ad is loading...
CYTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KRONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CLIX41.860.81
+1.99%
ProShares Long Online/Short Stores ETF
REM22.250.27
+1.23%
iShares Mortgage Real Estate Capped ETF
DFIC26.240.18
+0.69%
Dimensional International Core Eq 2 ETF
BNDC21.480.05
+0.23%
FlexShares Core Select Bond ETF
NORW24.80-0.09
-0.35%
Global X MSCI Norway ETF

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with TVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then TVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
+0.83%
TVTX - CYTK
57%
Loosely correlated
-2.41%
VBIV - CYTK
44%
Loosely correlated
-4.24%
BCAB - CYTK
43%
Loosely correlated
+12.89%
KRON - CYTK
43%
Loosely correlated
+2.04%
IOVA - CYTK
42%
Loosely correlated
+0.87%
More

KRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRON has been loosely correlated with MDGL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KRON jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRON
1D Price
Change %
KRON100%
+2.04%
MDGL - KRON
44%
Loosely correlated
-0.54%
CYTK - KRON
42%
Loosely correlated
+0.83%
VERA - KRON
38%
Loosely correlated
+2.48%
AXON - KRON
38%
Loosely correlated
+0.65%
ARRY - KRON
37%
Loosely correlated
+3.85%
More